(Q44830018)

reason for preferred rank

6 December 2017

title

Effects of SDZ NVI-085, a putative subtype-selective α1-agonist, on canine cataplexy, a disorder of rapid eye movement sleep (English)

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90763-G

29 October 2022

Effects of SDZ NVI-085, a putative subtype-selective alpha 1-agonist, on canine cataplexy, a disorder of rapid eye movement sleep (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1687464

29 October 2022

1 reference

bridged-ring compounds

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1687464

29 October 2022

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90763-G

29 October 2022

author

Christian Guilleminault

4

object named as

C Guilleminault

1 reference

6 December 2017

3

W C Dement

1 reference

6 December 2017

A. Renaud

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1687464

29 October 2022

S. Nishino

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1687464

29 October 2022

E. Mignot

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1687464

29 October 2022

language of work or name

English

0 references

publication date

1 November 1991

1 reference

6 December 2017

19 November 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1687464

full work available at URL

29 October 2022

https://api.elsevier.com/content/article/PII:001429999190763G?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90763-G

https://api.elsevier.com/content/article/PII:001429999190763G?httpAccept=text/plain

29 October 2022

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90763-G

European Journal of Pharmacology

29 October 2022

published in

1 reference

6 December 2017

volume

205

1 reference

6 December 2017

issue

1

1 reference

6 December 2017

page(s)

11-16

1 reference

(+)-Niguldipine binds with very high affinity to Ca2+ channels and to a subtype of alpha 1-adrenoceptors

6 December 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90763-G

5-Methyl-urapidil discriminates between subtypes of the alpha 1-adrenoceptor

29 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90763-G

Alpha 1-adrenoceptor subtypes linked to different mechanisms for increasing intracellular Ca2+ in smooth muscle

29 October 2022

6

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90763-G

Role of central alpha-1 adrenoceptors in canine narcolepsy

29 October 2022

7

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90763-G

Evidence for multiple [3H]prazosin binding sites in canine brain membranes.

29 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90763-G

Central alpha 1 adrenoceptor subtypes in narcolepsy-cataplexy: a disorder of REM sleep.

29 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90763-G

Identification of subtypes of [3H]prazosin-labelled alpha 1 receptor binding sites in rat brain

29 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90763-G

The role of alpha 1-adrenoceptor subtypes in the regulation of arterial blood pressure

29 October 2022

14

1 reference

https://api.crossref.org/works/10.1016/0014-2999(91)90763-G

29 October 2022

Identifiers

1 reference

6 December 2017

1 reference